Moriah Rabin, MD

Moriah Rabin, MD, is an attending physician at the Children’s Hospital at Montefiore Einstein (CHAM) and Assistant Professor, Pediatrics at our Albert Einstein College of Medicine. Her clinical focus is on the treatment of children with leukemia and lymphoma, and childhood cancer survivorship. She is the director of the Reassessment and Evaluation After Cancer Treatment (REACT) survivorship clinic at CHAM.

After receiving her Bachelor of Arts from Barnard College, Columbia University in 2009, Dr. Rabin earned her Doctor of Medicine at Einstein in 2014. For her medical training, she stayed at Einstein and CHAM, first completing her residency in pediatrics in 2017, after which she was selected to take an additional year as Chief Resident, then completing her fellowship in pediatric hematology and oncology in 2021.

Dr. Rabin’s research centers on novel immunotherapeutic approaches, particularly the use of CAR T cells, to improve treatment outcomes and decrease late effects of cancer therapy for pediatric cancer patients. Her research interests also include improving the medical, cognitive, psychosocial and reproductive outcomes for childhood, adolescent and young adult cancer survivors. Dr. Rabin's work has been widely presented at national conferences and published in leading peer-reviewed journals.

Dr. Rabin is board certified by the American Board of Pediatrics in both General Pediatrics and Pediatric Hematology-Oncology. She is a member of the American Academy of Pediatrics, the American Society of Pediatric Hematology/Oncology, the American Society of Hematology and the Children’s Oncology Group. In 2021, Dr. Rabin was inducted into the Alpha Omega Alpha Medical Honor Society. She is a recipient of the Leo M. Davidoff Society Award for Excellence in Teaching Medical Students.